Skip to main content

Correction to: Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis

The Original Article was published on 19 July 2019

Correction to: J Exp Clin Cancer Res

https://doi.org/10.1186/s13046-019-1321-x

In the original publication of this manuscript [1], the Fig. 6a invasion si-hsa_circ_0058124_2# group (row 2 right and row 3 right) and Fig. 9c TPC-1 clone formation assay control group (row 1 left) were misplaced and need to be revised. The updated figures are shown below.

The authors apologize for the inconvenience that the corrections caused.

Fig. 6
figure 1

Hsa_circ_0058124 affects the migration, invasion abilities, and apoptosis of PTC cells in vitro. a Representative images and quantification results of cell migration and invasion abilities of TPC-1 and K1 cells harboring control or hsa_circ_0058124 siRNAs. b Scratch wound assays in hsa_circ_0058124-deficient PTC cells and corresponding controls. c, d Flow cytometry assays showed the rate of apoptosis (c) and the cell cycle distributions (d) in TPC-1 cells transfected with si-NC or si-hsa_circ_0058124. *P < 0.05, **P < 0.01 and ***P < 0.001

Fig. 9
figure 2

The oncogenic hsa_circ_0058124/NOTCH3/GATAD2A axis in PTC cells. a Expression of Notch3 and GATAD2A in TPC-1 cells at protein level analyzed by western blot, after transfection with the indicated siRNAs. b, c The CCK-8 assays (b) and colony formation assays (c) were used to evaluate the cell growth after transfection with si-hsa_circ_0058124 or co-transfected with si-hsa_circ_0058124 and si-GATAD2A or si-NC in PTC cells. d Transwell assays were applied to evaluate the migration and invasion of PTC cells after transfection with si-hsa_circ_0058124 or co-transfected with si-hsa_circ_0058124 and si-GATAD2A or si-NC. e Immunohistochemistry analysis of GATAD2A protein levels in PTC tissues. Representative images were shown. Scale bar, 100 μm. f Representative images for the expression of GATAD2A in thyroid tumor tissues and normal thyroid tissues are shown with the fraction of samples with antibody staining/protein expressions evaluated as high, medium, low, or not detected based on the blue-scale color coding. Data are presented as the mean ± S.E.M., analyzed using independent samples student’s t-test. *P < 0.05, **P < 0.01 and ***P < 0.001

Reference

  1. Yao, et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 2019;38:318.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yun Chen or Yuan Zhang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yao, Y., Chen, X., Yang, H. et al. Correction to: Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res 39, 56 (2020). https://doi.org/10.1186/s13046-020-01560-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-020-01560-8